Skip to main navigation Skip to search Skip to main content

Analysis of regulatory B cells in experimental autoimmune uveitis

  • National Institutes of Health

Research output: Contribution to conferenceChapterpeer-review

Abstract

Regulatory B cells (Bregs) that produce IL-35 and IL-10 (i35-Bregs) regulate central nervous system (CNS) autoimmune diseases including uveitis. In the mouse model of uveitis, i35-Breg cells suppress intraocular inflammation by inducing expansion of IL-10-producing B cells (B10), IL-10-producing T cells (Tregs), and IL-35-producing T cells (iTR35), suggesting that i35-Bregs orchestrate an immune-suppressive milieu that regulates immunity during autoimmune diseases. In this chapter, we discuss uveitis and therapeutic challenges that necessitate the development of cell-based therapies for the treatment of these potentially blinding diseases that cause 10% visual handicap. We then describe the methods we set up for ex vivo generation of i35-Breg cells employed in i35-Breg immunotherapy in uveitis and in other CNS autoimmune diseases.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages437-450
Number of pages14
DOIs
StatePublished - 2021

Publication series

NameMethods in Molecular Biology
Volume2270
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Keywords

  • CNS autoimmune disease
  • EAU
  • i35-Breg
  • IL-10
  • IL-35
  • Regulatory B cells
  • Uveitis

Quacquarelli Symonds(QS) Subject Topics

  • Biological Sciences

Fingerprint

Dive into the research topics of 'Analysis of regulatory B cells in experimental autoimmune uveitis'. Together they form a unique fingerprint.

Cite this